Amgen: all 1,085 studies

Page 2 of 11. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisCompletedNCT04607980Phase 3Results posted
• Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized PatientsCompletedNCT04590586Phase 3Results posted
• A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye DiseaseCompletedNCT04583735Phase 4Results posted
• Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis ImperfectaCompletedNCT04545554Phase 1Results posted
• A Study of Inebilizumab Efficacy and Safety in IgG4- Related DiseaseActive, not recruitingNCT04540497Phase 3Results posted
• Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALLCompletedNCT04524455Phase 1Results posted
• Myasthenia Gravis Inebilizumab TrialActive, not recruitingNCT04524273Phase 3Results posted
• Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving MethotrexateCompletedNCT04511702Phase 4Results posted
• Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)TerminatedNCT04506086Phase 4Results posted
• A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)TerminatedNCT04478994Phase 1Results posted
• Single and Multiple Ascending Dose Study of AMG 133 in Participants With ObesityCompletedNCT04478708Phase 1Results posted
• Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT04478695Phase 1Results posted
• AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).CompletedNCT04380753Phase 1Results posted
• Study of AMG 256 in Adult Subjects With Advanced Solid TumorsCompletedNCT04362748Phase 1Results posted
• Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).CompletedNCT04303780Phase 3Results posted
• Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding StudyCompletedNCT04270760Phase 2Results posted
• A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]CompletedNCT04270747Phase 3Results posted
• Biomarker and Genetic Predictors of Erenumab Treatment ResponseCompletedNCT04265755Phase 4Results posted
• Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction AdenocarcinomaTerminatedNCT04260191Phase 1Results posted
• Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic MigraineCompletedNCT04252742Phase 4Results posted
• Single and Multiple Ascending Dose Study of AMG 171 in Subjects With ObesityTerminatedNCT04199351Phase 1Results posted
• Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib TripletCompletedNCT04191616Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid ArthritisCompletedNCT04163991Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's SyndromeCompletedNCT04129164Phase 2Results posted
• Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney TransplantCompletedNCT04087720Phase 4Results posted
• FPT155 in Patients With Advanced Solid TumorsTerminatedNCT04074759Phase 1Results posted
• Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).CompletedNCT04068181Phase 2Results posted
• Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)CompletedNCT04058028Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar PustulosisCompletedNCT04057937Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney TransplantCompletedNCT04046549Phase 2Results posted
• Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled GoutCompletedNCT03994731Phase 4Results posted
• A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse HeadacheCompletedNCT03971071Phase 4Results posted
• Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple MyelomaCompletedNCT03934684Phase 4Results posted
• A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical TherapyCompletedNCT03930186Phase 3Results posted
• Study of Sustained Benefit of AMG334 in Adult Episodic Migraine PatientsCompletedNCT03927144Phase 4Results posted
• Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic MigraineTerminatedNCT03912337Phase 4Results posted
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or StrokeCompletedNCT03872401Phase 3Results posted
• A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaCompletedNCT03859427Phase 3Results posted
• AMG 404 in Patients With Advanced Solid TumorsCompletedNCT03853109Phase 1Results posted
• Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)CompletedNCT03852472Phase 2Results posted
• Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple MyelomaTerminatedNCT03836053Phase 1Results posted
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal WomenCompletedNCT03822078Phase 1Results posted
• A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNHCompletedNCT03818607Phase 3Results posted
• A Controlled Trial of Erenumab in Migraine PreventionCompletedNCT03812224Phase 3Results posted
• A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic DermatitisTerminatedNCT03809663Phase 2Results posted
• A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic ArthritisCompletedNCT03783026Phase 4Results posted
• Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid ArthritisTerminatedNCT03781375Phase 3Results posted
• Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)CompletedNCT03780959Phase 2/3Results posted
• An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital PsoriasisCompletedNCT03777436Phase 3Results posted
• A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of LifeCompletedNCT03774875Phase 4Results posted
• Multiple Ascending Dose Study of AMG 598 in Adults With ObesityCompletedNCT03757130Phase 1Results posted
• Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.CompletedNCT03747939Phase 4Results posted
• Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and EfficacyCompletedNCT03721172Phase 3Results posted
• A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic SyndromeTerminatedNCT03703908Phase 2Results posted
• Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque PsoriasisCompletedNCT03701763Phase 3Results posted
• A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction CancerCompletedNCT03694522Phase 2Results posted
• Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis ImperfectaTerminatedNCT03638128Phase 3Results posted
• Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled GoutCompletedNCT03635957Phase 4Results posted
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a)CompletedNCT03626662Phase 1Results posted
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular LymphomaTerminatedNCT03571828Phase 1Results posted
• Imaging of Coronary Plaques in Participants Treated With EvolocumabCompletedNCT03570697Phase 3Results posted
• Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT03541369Phase 1Results posted
• A Study of CCX140-B in Subjects With FSGSCompletedNCT03536754Phase 2Results posted
• FPA150 in Patients With Advanced Solid TumorsTerminatedNCT03514121Early Phase 1Results posted
• A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology CentersTerminatedNCT03512353Phase 2Results posted
• AMG 334 20160172 Pediatric Migraine PK Study.CompletedNCT03499119Phase 1Results posted
• Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)CompletedNCT03476239Phase 3Results posted
• Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological MalignanciesTerminatedNCT03465540Phase 1Results posted
• Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension StudyCompletedNCT03461211Phase 3Results posted
• A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.CompletedNCT03456856Phase 4Results posted
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus ErythematosusCompletedNCT03451422Phase 1Results posted
• Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed DyslipidemiaTerminatedNCT03433755Phase 3Results posted
• A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for OsteoporosisCompletedNCT03432533Phase 3Results posted
• Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host DiseaseTerminatedNCT03422627Phase 1/2Results posted
• Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid ArthritisTerminatedNCT03410056Phase 1/2Results posted
• Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial HypercholesterolemiaCompletedNCT03403374Phase 4Results posted
• Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerCompletedNCT03362177Phase 3Results posted
• A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal CancerCompletedNCT03343301Phase 1Results posted
• Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)CompletedNCT03340766Phase 1Results posted
• Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs)CompletedNCT03335488Phase 4Results posted
• Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal FunctionCompletedNCT03318809Phase 1Results posted
• Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004CompletedNCT03301857Phase 4Results posted
• Controlled Trial Evaluating Avacopan in C3 GlomerulopathyCompletedNCT03301467Phase 2Results posted
• Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)CompletedNCT03299244Phase 3Results posted
• Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical StudyCompletedNCT03298867Phase 3Results posted
• Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)TerminatedNCT03298412Phase 2Results posted
• Study of AMG 596 in Patients With EGFRvIII Positive GlioblastomaTerminatedNCT03296696Phase 1Results posted
• A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416CompletedNCT03283098Phase 1Results posted
• Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure PatientsTerminatedNCT03276728Phase 1Results posted
• Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver MetastasesCompletedNCT03256344Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine PreventionCompletedNCT03238781Phase 2Results posted
• Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)TerminatedNCT03224819Early Phase 1Results posted
• AMG 529 First in Human StudyCompletedNCT03170193Phase 1Results posted
• Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced OsteoporosisCompletedNCT03164928Phase 3Results posted
• Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.CompletedNCT03158688Phase 3Results posted
• Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid ArthritisCompletedNCT03156023Phase 1Results posted
• A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the ScalpCompletedNCT03123471Phase 3Results posted
• Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European CountriesTerminatedNCT03080935Phase 3Results posted
• Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant MelanomaCompletedNCT03064763Phase 1Results posted
• Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple MyelomaCompletedNCT03029234Phase 3Results posted

← Amgen overview and focus areas